Skip to content
PubMed This is a summary of 17 peer-reviewed journal articles Updated
Gynecology · Premenstrual Dysphoric Disorder

The Path to Relief: Standard Care and Treatment Options

At a Glance

For PMDD and severe PMS, treatment often starts with an antidepressant called an SSRI, taken daily or only during the second half of the menstrual cycle. Other options include drospirenone birth control, therapy, exercise, calcium, and specialist care when symptoms remain severe.

Treating PMDD and severe PMS often requires a “multimodal” approach—using a combination of different strategies to address the complex way your brain and body respond to hormone shifts [1]. Because every person’s experience is unique, you and your doctor may need to try several options to find the right balance of symptom relief and minimal side effects [2][3].

First-Line Pharmacological Care: SSRIs

Selective Serotonin Reuptake Inhibitors (SSRIs) are considered the “gold standard” and first-line medication for PMDD and severe PMS [4][5]. Unlike their use in chronic depression, where they can take weeks to work, SSRIs often provide relief for PMDD symptoms within just a few days [6].

Dosing Schedules

There are two primary ways your doctor might prescribe an SSRI. Both are valid options, and the choice is highly individualized:

  • Continuous Dosing: You take the medication every day of the month. This may be more effective for overall symptom reduction and is often recommended if you also have underlying anxiety or depression [4][6].
  • Luteal-Phase Dosing: You take the medication only during the second half of your cycle, starting around ovulation and stopping when your period begins [7][8]. This can help minimize side effects and is a valid option if your symptoms fully resolve during the rest of the month [4].

Common SSRIs and Safety Considerations

Commonly used SSRIs include fluoxetine, sertraline, and escitalopram [4]. While effective, they can cause side effects such as nausea, insomnia, fatigue, dizziness, or a decrease in sexual desire (libido) [4].

Because SSRIs can carry a risk of “activation” or triggering manic episodes in susceptible individuals, your clinician should screen you for bipolar-spectrum symptoms before prescribing them. SSRIs can also interact with other medications and cause a significant “discontinuation syndrome” if stopped abruptly, so you should never start, stop, or change your dose without consulting your prescriber. (If you are pregnant or breastfeeding, be sure to discuss specific considerations with your doctor, as risk profiles vary). If one SSRI causes intolerable side effects, your doctor may suggest switching to a different one or adjusting the dose [2].

Second-Line Care: Hormonal Management

If SSRIs are not effective or not preferred, hormonal treatments that suppress ovulation may be recommended [5][9]. Note that not every hormonal method suppresses ovulation or improves mood; in fact, hormonal contraception can worsen mood for some people, requiring careful monitoring [2].

The most evidence-supported hormonal option is a Combined Oral Contraceptive (COC) containing a specific progestin called drospirenone paired with low-dose ethinyl estradiol [10][9]. Research specifically highlights a 24/4 regimen (24 active pills and 4 inactive pills) as being effective for improving physical symptoms, emotional symptoms, and daily functioning [10][9].

Hormonal options carry specific risks, particularly those containing estrogen. They may be contraindicated if you have a history of blood clots, stroke, migraine with aura, uncontrolled hypertension, liver disease, or if you smoke and are over age 35. Common side effects include breast pain, nausea, and irregular spotting between periods [10].

Evidence-Based Lifestyle & Supplements

For many, lifestyle adjustments are an essential foundation of care, though they may be most effective for milder symptoms or when used alongside medication [11].

  • Cognitive Behavioral Therapy (CBT): This specialized form of talk therapy can help you develop coping strategies for the intense emotional shifts of PMDD, potentially reducing the overall burden of the condition [6][12].
  • Calcium Supplementation: Of all the nutritional supplements, combining dietary calcium intake and supplements has the most consistent evidence for reducing the severity of premenstrual symptoms [13][5]. Note that excessive calcium supplementation can increase the risk of kidney stones, so discuss your total dietary and supplemental intake with your provider.
  • Regular Exercise: Engaging in regular aerobic exercise (like brisk walking or swimming) has been shown to alleviate both physical and psychological symptoms in many patients [14][11].
  • A Note on Supplements: “Natural” products are not automatically safe and should always be reviewed with a clinician or pharmacist. While Vitamin B6 and Chasteberry (Vitex) have shown some promise in small studies, high or cumulative doses of Vitamin B6 can cause peripheral neuropathy (nerve damage), and Chasteberry can interact with other medications and hormones [15][16]. The evidence for these—and for Vitamin D—is currently less robust and less consistent than the evidence for calcium or SSRIs [12].

When Standard Care Isn’t Enough

For “refractory” cases—where symptoms remain severe despite trying SSRIs and birth control—more intensive options may be considered. These include GnRH agonists, which put the body into a temporary, reversible “medical menopause” to completely stop the hormonal cycle, or in very rare and extreme cases, surgical removal of the ovaries [3][17]. These treatments are typically managed by specialists and require careful monitoring of bone and heart health [1].

Common questions in this guide

What medicine is usually tried first for PMDD or severe PMS?
Selective serotonin reuptake inhibitors (SSRIs) are usually the first medication option for PMDD and severe PMS. Fluoxetine, sertraline, and escitalopram are commonly used. They may improve PMDD symptoms within a few days, but a clinician should choose the medication and dose.
Should I take an SSRI every day or only before my period?
An SSRI may be taken every day or only during the second half of the menstrual cycle, starting around ovulation and stopping when bleeding begins. Daily treatment may be preferred when symptoms continue throughout the month or anxiety or depression is also present; cycle-based treatment may reduce side effects when symptoms fully resolve outside that phase. Do not change the schedule or stop suddenly without speaking with your prescriber.
Can drospirenone birth control improve PMDD symptoms?
A combined birth-control pill containing drospirenone and low-dose ethinyl estradiol, especially a 24-day active-pill and 4-day inactive-pill schedule, has evidence for improving emotional and physical symptoms and daily functioning. Hormonal contraception does not help everyone and can worsen mood in some people. Estrogen-containing pills may be unsafe with a history of clots, stroke, migraine with aura, uncontrolled hypertension, liver disease, or smoking after age 35, so clinician review is important.
Can therapy, exercise, or supplements help with PMDD?
Cognitive behavioral therapy and regular aerobic exercise can help reduce emotional and physical symptoms, especially as part of a broader treatment plan. Among supplements, calcium has the most consistent evidence. Vitamin B6, chasteberry, and vitamin D have less consistent evidence, and supplements can interact with medicines or cause harm.
Why should bipolar symptoms be checked before starting an SSRI for PMDD?
SSRIs can cause activation or trigger a manic episode in people with bipolar-spectrum illness. A clinician should screen for bipolar-spectrum symptoms and discuss any history of mania before prescribing. This screening helps guide safer treatment.
What happens if SSRIs and birth control do not control severe PMDD symptoms?
For severe symptoms that persist despite standard treatment, a specialist may consider a gonadotropin-releasing hormone (GnRH) agonist. It temporarily and reversibly stops the hormonal cycle, creating a medical-menopause state, and requires monitoring of bone and heart health. Surgery to remove the ovaries is reserved for very rare, extreme cases.

Get notified when new evidence is published on premenstrual tension.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (17)
  1. 1

    Management of Premenstrual Disorders: ACOG Clinical Practice Guideline No. 7.

    Obstetrics and gynecology 2023; (142(6)):1516-1533 doi:10.1097/AOG.0000000000005426.

    PMID: 37973069
  2. 2

    Premenstrual syndrome: A mini review.

    Ryu A, Kim TH

    Maturitas 2015; (82(4)):436-40.

    PMID: 26351143
  3. 3

    Management of Premenstrual Dysphoric Disorder: A Scoping Review.

    Carlini SV, Lanza di Scalea T, McNally ST, et al.

    Focus (American Psychiatric Publishing) 2024; (22(1)):81-96 doi:10.1176/appi.focus.23021035.

    PMID: 38694162
  4. 4

    Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder.

    Jespersen C, Lauritsen MP, Frokjaer VG, Schroll JB

    The Cochrane database of systematic reviews 2024; (8()):CD001396 doi:10.1002/14651858.CD001396.pub4.

    PMID: 39140320
  5. 5

    Premenstrual Dysphoric Disorder.

    Lanza di Scalea T, Pearlstein T

    The Psychiatric clinics of North America 2017; (40(2)):201-216 doi:10.1016/j.psc.2017.01.002.

    PMID: 28477648
  6. 6

    [Premenstrual dysphoric disorder (PMDD): Drug and psychotherapeutique management, a literature review].

    Marais-Thomas H, Chapelle F, de Vaux-Boitouzet V, Bouvet C

    L'Encephale 2024; (50(2)):211-232 doi:10.1016/j.encep.2023.08.007.

    PMID: 37821319
  7. 7

    Intermittent selective serotonin reuptake inhibitors for premenstrual syndromes: A systematic review and meta-analysis of randomised trials.

    Reilly TJ, Wallman P, Clark I, et al.

    Journal of psychopharmacology (Oxford, England) 2023; (37(3)):261-267 doi:10.1177/02698811221099645.

    PMID: 35686687
  8. 8

    Symptom-Onset Dosing of Sertraline for the Treatment of Premenstrual Dysphoric Disorder: A Randomized Clinical Trial.

    Yonkers KA, Kornstein SG, Gueorguieva R, et al.

    JAMA psychiatry 2015; (72(10)):1037-44 doi:10.1001/jamapsychiatry.2015.1472.

    PMID: 26351969
  9. 9

    Contraception counseling for women with premenstrual dysphoric disorder (PMDD): current perspectives.

    Rapkin AJ, Korotkaya Y, Taylor KC

    Open access journal of contraception 2019; (10()):27-39 doi:10.2147/OAJC.S183193.

    PMID: 31572029
  10. 10

    Oral contraceptives containing drospirenone for premenstrual syndrome.

    Ma S, Song SJ

    The Cochrane database of systematic reviews 2023; (6()):CD006586 doi:10.1002/14651858.CD006586.pub5.

    PMID: 37365881
  11. 11

    Premenstrual syndrome, a common but underrated entity: review of the clinical literature

    Dilbaz B, Aksan A

    Journal of the Turkish German Gynecological Association 2021; (22(2)):139-148 doi:10.4274/jtgga.galenos.2021.2020.0133.

    PMID: 33663193
  12. 12

    Premenstrual Syndrome and Premenstrual Dysphoric Disorder.

    Hofmeister S, Bodden S

    American family physician 2016; (94(3)):236-40.

    PMID: 27479626
  13. 13

    A Comprehensive Review of Treatment Options for Premenstrual Syndrome and Premenstrual Dysphoric Disorder.

    Maharaj S, Trevino K

    Journal of psychiatric practice 2015; (21(5)):334-50 doi:10.1097/PRA.0000000000000099.

    PMID: 26352222
  14. 14

    Premenstrual Syndrome and Premenstrual Dysphoric Disorder's Impact on Quality of Life, and the Role of Physical Activity.

    Liguori F, Saraiello E, Calella P

    Medicina (Kaunas, Lithuania) 2023; (59(11)) doi:10.3390/medicina59112044.

    PMID: 38004093
  15. 15

    A Pilot Randomized Treatment-Controlled Trial Comparing Vitamin B6 with Broad-Spectrum Micronutrients for Premenstrual Syndrome.

    Retallick-Brown H, Blampied N, Rucklidge JJ

    Journal of alternative and complementary medicine (New York, N.Y.) 2020; (26(2)):88-97 doi:10.1089/acm.2019.0305.

    PMID: 31928364
  16. 16

    Vitex agnus castus for premenstrual syndrome and premenstrual dysphoric disorder: a systematic review.

    Cerqueira RO, Frey BN, Leclerc E, Brietzke E

    Archives of women's mental health 2017; (20(6)):713-719 doi:10.1007/s00737-017-0791-0.

    PMID: 29063202
  17. 17

    Management of Premenstrual Dysphoric Disorder: A Scoping Review.

    Carlini SV, Lanza di Scalea T, McNally ST, et al.

    International journal of women's health 2022; (14()):1783-1801 doi:10.2147/IJWH.S297062.

    PMID: 36575726

This page is for informational purposes only and does not constitute medical advice about PMDD or severe PMS. Discuss medication, hormonal treatment, supplements, and any dose changes with your clinician.